Meta‐analysis: insulin resistance and sustained virological response in hepatitis C

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2011.04716.xPMID 21623851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

  2011cited by this paper
• Insulin Assay Standardization

  2010cited by this paper
• Insulin Resistance Predicts Rapid Virologic Response to Peginterferon/Ribavirin Combination Therapy in Hepatitis C Genotype 4 Patients

  2010cited by this paper
• Insulin Assay Standardization: Leading to Measures of Insulin Sensitivity and Secretion for Practical Clinical Care

  2010cited by this paper
• Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

  2010cited by this paper
• Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: Impact of obesity and ethnicity

  2010cited by this paper
• Insulin Assay Standardization: Leading to Measures of Insulin Sensitivity and Secretion for Practical Clinical Care

  2010cited by this paper
• Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.

  2009cited by this paper
• Toward standardization of insulin immunoassays.

  2009cited by this paper
• Diagnosis, management, and treatment of hepatitis C: An update

  2009cited by this paper
• Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin.

  2009cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis C

  2009cited by this paper
• Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus

  2009cited by this paper
• Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4

  2009cited by this paper
• Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.

  2009cited by this paper
• Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α‐2b plus ribavirin

  2009cited by this paper
• Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.

  2009cited by this paper
• Targeting host factors: a novel rationale for the management of hepatitis C virus.

  2009influential reference
• Hyperinsulinaemia reduces the 24‐h virological response to PEG‐interferon therapy in patients with chronic hepatitis C and insulin resistance

  2009cited by this paper
• Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C

  2009cited by this paper
• The history of the “natural history” of hepatitis C (1968–2009)

  2009cited by this paper
• Improved outcomes in patients with hepatitis C with difficult‐to‐treat characteristics: Randomized study of higher doses of peginterferon α‐2a and ribavirin

  2008cited by this paper
• Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis.

  2008cited by this paper
• Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.

  2008cited by this paper
• Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load

  2008influential reference
• Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

  2008cited by this paper
• Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.

  2008cited by this paper
• Race, insulin resistance and hepatic steatosis in chronic hepatitis C

  2007cited by this paper
• The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype‐specific mechanisms

  2007cited by this paper
• Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

  2007cited by this paper
• New hepatitis C guidelines for the Asia–Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

  2007cited by this paper
• Clearance of HCV Improves Insulin Resistance, Beta-Cell Function, and Hepatic Expression of Insulin Receptor Substrate 1 and 2

  2007cited by this paper
• Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C

  2006cited by this paper
• Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

  2005cited by this paper
• Weekly epidemiological record Relevé épidémiologique hebdomadaire

  2005cited by this paper
• Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

  2004cited by this paper
• Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?

  2004cited by this paper
• The epidemiology of acute and chronic hepatitis C.

  1997cited by this paper
• Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

  1994cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985influential reference

• Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection

  2025cites this paper
• Interferon Upregulation Associates with Insulin Resistance in Humans.

  2024cites this paper
• Liver Disease Outcomes after Sustained Virological Response in Patients with Chronic Hepatitis C Infection Treated with Generic Direct-Acting Antivirals.

  2022cites this paper
• Performance and comparison of artificial intelligence and human experts in the detection and classification of colonic polyps

  2022cites this paper
• Veränderungen der Hepatitis-C-Virus-Genotyp-1a/1b-Verteilung zwischen 2004 und 2018 in Deutschland – eine Analyse von 17093 Patienten aus verschiedenen Real-World-Registern

  2021cites this paper
• Natural History of Hepatitis C Infection

  2021cites this paper
• Insulin resistance in children with chronic hepatitis C and its association with response to IFN-alpha and ribavirin

  2021cites this paper
• The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection

  2020cites this paper
• Insulin resistance in children with chronic hepatitis C and its association with response to IFN-alpha and ribavirin.

  2020cites this paper
• Clinical parallels and experience of antivira l therapy in chronic hepatitis with polycystic ovary syndrome

  2020cites this paper
• Positive association between dietary acid load and future insulin resistance risk: findings from the Korean Genome and Epidemiology Study

  2020cites this paper
• COVID-19: Importancia de la resistencia a la insulina en la respuesta a la terapia antiviral con interferón

  2020cites this paper
• Resistencia a la insulina en niños con hepatitis C crónica y su asociación con la respuesta al IFN-alfa y ribavirina

  2020cites this paper
• The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.

  2020cites this paper
• Noninvasive biomarkers predict improvement in liver fibrosis after successful generic DAAs based therapy of chronic hepatitis C in Egypt

  2020cites this paper
• Клинические параллели и опыт противовирусной терапии при хроническом гепатите с синдромом поликистозных яичников

  2020cites this paper
• Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment

  2019cites this paper
• [Type 2 diabetes mellitus, insulin resistance and hepatocellular carcinoma in chronic hepatitis C patients. Data from Northeastern Hungary].

  2019cites this paper
• Effect of HCV treatment response on insulin resistance: A systematic review and meta-analysis

  2019cites this paper
• The association of hepatitis c virus infection status with serum glucose levels

  2019cites this paper
• IMPACT OF INSULIN RESISTANCE AND SERUM ZINC ON RESPONSE TO PEG-INTERFERON/RIBAVIRIN COMBINATION THERAPY IN NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C

  2019cites this paper
• Hepatitis C Virus ( HCV ) Genotyping and its Clinical Utility for Disease Monitoring

  2018cites this paper
• Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges

  2018cites this paper
• Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C

  2018cites this paper
• Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus

  2018cites this paper
• INSULIN RESISTANCE IN CHRONIC HEPATITIS C VIRUS PATIENTS RECEIVING DIRECT ACTING ANTIVIRAL DRUGS By ZAINAB

  2018cites this paper
• DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS?

  2018cites this paper
• Diabetes, Specific Hepatobiliary Diseases, and Treatment

  2017cites this paper
• High prevalence of insulin resistance among Brazilian chronic hepatitis C patients

  2017cites this paper
• Mortality associated with gastrointestinal bleeding in children: A retrospective cohort study

  2017cites this paper
• Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents.

  2017cites this paper
• Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

  2017cites this paper
• Hepatitis C–Associated Diabetes Mellitus Hepatitis C–Associated Diabetes Mellitus

  2017cites this paper
• Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C.

  2017cites this paper
• Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review

  2017cites this paper
• Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C.

  2017cites this paper
• Rheumatologic Manifestations of Hepatitis C Virus Infection.

  2017cites this paper
• Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation.

  2017cites this paper
• Hepatitis C–Associated Diabetes Mellitus

  2017cites this paper
• The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice.

  2017cites this paper
• Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes

  2016cites this paper
• Hepatitis C and insulin action: An intimate relationship.

  2016cites this paper
• Hepatitis C Virus, Insulin Resistance, and Steatosis

  2016cites this paper
• [Chronic HCV infection: An internist's opinion (Part 2)].

  2016cites this paper
• Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial

  2016cites this paper
• n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial.

  2016cites this paper
• Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

  2016cites this paper
• Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes

  2016cites this paper
• Hepatit is C Virus Infection and Rheumatic Diseases The Impact of Direct-Acting Antiviral Agents

  2016cites this paper
• Extrahepatic morbidity and mortality of chronic hepatitis C.

  2015cites this paper
• Characterisation of the cytokine milieu associated with the up‐regulation of IL‐6 and suppressor of cytokine 3 in chronic hepatitis C treatment non‐responders

  2015cites this paper
• Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian Patients

  2015cites this paper
• HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients

  2015cites this paper
• Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’

  2015cites this paper
• Diagnosis and Management of Hepatitis C.

  2015cites this paper
• Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients.

  2015cites this paper
• Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection.

  2015cites this paper
• Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy

  2015cites this paper
• Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study

  2015cites this paper
• Hepatitis C virus infection, metabolic disorders and non-alcoholic fatty liver disease: a literature review.

  2015cites this paper
• Sustained Virologic Response to a Dual Peginterferon alfa-2a and Ribavirin in Treating Chronic hepatitis C Infection

  2015cites this paper
• Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C

  2014cites this paper
• Review article: HCV genotype 3 – the new treatment challenge

  2014cites this paper
• HEPATITIS C ( M BOURLIÈRE AND TASSELAH , SECTION EDITORS ) Optimal Management of HIV-HCV Coinfection

  2014cites this paper
• IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV‐coinfected patients

  2014cites this paper
• Dietary Determinants of Metabolic Syndrome and Its Components in Korean Adults

  2014cites this paper
• Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.

  2014cites this paper
• Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro

  2014cites this paper
• Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?

  2014cites this paper
• Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases.

  2014cites this paper
• Update : Hepatitis C Facts and fictions of HCV and comorbidities : Steatosis , diabetes mellitus , and cardiovascular diseases

  2014cites this paper
• Does telaprevir possess a direct antidiabetic effect?

  2014cites this paper
• Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

  2014cites this paper
• Individualization of chronic hepatitis C treatment according to the host characteristics.

  2014cites this paper
• Effect of Iron-Mediated Oxidative Stress on Insulin Resistance through the Forkhead Box-Containing Protein O Subfamily-1 (FOXO-1) Pathway in Chronic Hepatitis C *

  2013cites this paper
• Diabetes mellitus and decompensated cirrhosis: Risk of hepatic encephalopathy in different age groups (糖尿病与失代偿性肝硬化：不同年龄组的肝性脑病风险)

  2013cites this paper
• Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.

  2013cites this paper
• Association between vitamin D and hepatitis C virus infection: a meta-analysis.

  2013cites this paper
• Who is more likely to respond to dual treatment with pegylated‐interferon and ribavirin for chronic hepatitis C? A gender‐oriented analysis

  2013cites this paper
• Extrahepatic Manifestations of Hepatitis C Virus Infection

  2013cites this paper
• The relationship between intake of nutrients and food groups and insulin resistance in Korean adults: Using the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV, 2007-2009)

  2013cites this paper
• Avaliação da resistência à insulina em pacientes com hepatite C crônica não diabéticos

  2013cites this paper
• Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis

  2013cites this paper
• Diabetes worsening of hepatitis C cirrhosis: are alterations in monocytic tissue factor (CD 142) is the cause?

  2013cites this paper
• Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial

  2013cites this paper
• Associations of chronic hepatitis C with metabolic and cardiac outcomes

  2013cites this paper
• Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism

  2013cites this paper
• Insulin resistance, telaprevir, and virological response in hepatitis C: The debate must go on

  2013cites this paper
• Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?

  2013cites this paper
• Poor response to hepatitis C treatment in elderly patients.

  2013cites this paper
• Whole-body insulin resistance is associated with elevated serum α-fetoprotein levels in patients with chronic hepatitis C.

  2013cites this paper
• Polypharmacy and Comorbidity Are Associated with a Lower Early Virologic Response in Hepatitis C Patients Treated with First Generation Protease Inhibitor Triple Therapy: A Preliminary Analysis

  2013cites this paper
• Type 2 Diabetes Mellitus and the Risk of Hepatitis C Virus Infection: A systematic review

  2013cites this paper
• Dipeptidyl peptidase-4: a key player in chronic liver disease.

  2013cites this paper
• Insulin Versus Oral Hypoglycemic Drug Combination In Controlling Hyperglycemia In HCV Patients During Interferon Therapy

  2012cites this paper
• Motor vehicle accidents: how should cirrhotic patients be managed?

  2012cites this paper
• Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/HCV co- infected patients

  2012cites this paper
• Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cites this paper
• Insulin Resistance Impairs Viral Dynamics Independently of Ethnicity or Genotypes

  2012cites this paper
• Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1

  2012cites this paper